Scarica l'app Stockscreener
3.42
3.32%
0.11
Lantern Pharma Inc Azioni (LTRN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.52%
5.732
|
4.8774 | 3.5236 | 5.1903 | 4.2863 |
| Operating Income/Loss |
17.52%
-5.732
|
-4.8774 | -3.5236 | -5.1903 | -4.2863 |
| Income/Loss From Continuing Operations Before Tax |
29.98%
-5.4408
|
-4.1859 | -3.1615 | -4.7464 | -3.8678 |
| Income/Loss From Continuing Operations After Tax |
29.98%
-5.4408
|
-4.1859 | -3.1615 | -4.7464 | -3.8678 |
|
Net Income/Loss
|
29.98%
-5.4408
|
-4.1859 | -3.1615 | -4.7464 | -3.8678 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
72,760%
10.74
|
-0.0148 | 10.86 | 10.86 | 10.86 |
| Diluted Average Shares |
72,760%
10.74
|
-0.0148 | 10.86 | 10.86 | - |
| Basic Earnings Per Share |
30.77%
-0.51
|
-0.39 | -0.29 | -0.44 | -0.36 |
| Diluted Earnings Per Share |
30.77%
-0.51
|
-0.39 | -0.29 | -0.44 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):